Short answer
HCA Healthcare (HCA) filed an 8-K current report with the SEC on June 18, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Dr. Michael Cuffe departing Executive Vice President and Chief Clinical Officer effective August 31, 2026.
HCA Healthcare 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Dr. Michael Cuffe departing Executive Vice President and Chief Clinical Officer effective August 31, 2026
- Transitional role continuing through February 2027, supporting leadership handoff
- Eligibility for executive severance benefits and applicable incentive plans, creating potential transition costs
- Clinical leadership succession and continuity become key investor watchpoints
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other HCA Healthcare 8-K filings
Get the next HCA 8-K as it lands
Follow HCA for push alerts, or ask the research agent what this filing means.